# Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects

> **NCT00684502** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 110 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** AZD2066
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00684502
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2010-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684502, "Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00684502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*